Cargando…
Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression
BACKGROUND: Substantial residual cardiovascular risk remains after optimal LDL lowering in patients of established coronary artery disease. A number of therapeutic agents that raise HDL-C have been tested in clinical trials to cover this risk. However, the results of clinical trials are conflicting....
Autores principales: | Kaur, Navjot, Pandey, Avaneesh, Negi, Harish, Shafiq, Nusrat, Reddy, Srinivas, Kaur, Harpreet, Chadha, Neelima, Malhotra, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984171/ https://www.ncbi.nlm.nih.gov/pubmed/24728455 http://dx.doi.org/10.1371/journal.pone.0094585 |
Ejemplares similares
-
Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis
por: Kaur, Navjot, et al.
Publicado: (2014) -
A meta-analysis to assess usefulness of procalcitonin-guided antibiotic usage for decision making
por: Shafiq, Nusrat, et al.
Publicado: (2017) -
Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India
por: Kaur, Sharonjeet, et al.
Publicado: (2014) -
Authors' response
por: Shafiq, Nusrat, et al.
Publicado: (2018) -
Shortage of essential antimicrobials: a major challenge to global health security
por: Shafiq, Nusrat, et al.
Publicado: (2021)